𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prophylactic administration of prostaglandin E1 in liver transplantation: Results of a pilot trial

✍ Scribed by E. Giostra; H. Chen; H. Deng; L. Buhler; J.A. Romand; A. Hadengue; O. Huber; P. Morel; G. Mentha

Book ID
117234967
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
295 KB
Volume
29
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A double-blind, randomized, placebo-cont
A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation
✍ Keith S. Henley; Michael R. Lucey; Daniel P. Normolle; Robert M. Merion; Ian D. πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 774 KB

A double-blind placebo-controlled trial of intravenous prostaglandin PGE, (40 pg/h) was conducted in adult orthotopic liver transplant recipients. Infusion was started intraoperatively and continued for up to 21 days. Patients were followed up for 180 days postoperatively. Among 172 patients eligibl

Controlled trial of prophylactic versus
Controlled trial of prophylactic versus therapeutic use of ganciclovir after liver transplantation in adults
✍ Alexander T. Cohen; John G. O'Grady; Sheena Sutherland; Richard Sallie; K.-C. Ta πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 538 KB

## Abstract The potential of prophylactic ganciclovir for the control of cytomegalovirus (CMV) infection was evaluated in a prospective controlled trial of 65 patients after liver transplantation. A group of 33 patients received ganciclovir (10 mg/kg/day) during the third and fourth weeks after tra